Augmentation of the anti-lymphoma activity of an anti-CD19 immunotoxin by anti-CD20 antibody is mediated via a complement-dependent mechanism.

被引：0
|
作者：
Flavell, DJ [1 ]
Warnes, SL [1 ]
Symons, M [1 ]
Noss, A [1 ]
Flavell, SU [1 ]
机构：
[1] Univ Southampton, Sch Med, Simon Flavell Leukemia Res Unit, Southampton, Hants, England
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1475
引用
收藏
页码：342A / 342A
页数：1
相关论文
共 50 条
  • [21] The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody
    Nahimana, Aimable
    Aubry, Dominique
    Breton, Caroline S.
    Majjigapu, Somi R.
    Sordat, Bernard
    Vogel, Pierre
    Duchosal, Michel A.
    LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 2141 - 2150
  • [22] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    T Oyama
    Y Kagami
    M Seto
    Y Morishima
    Leukemia, 2001, 15 : 1667 - 1667
  • [23] Mechanism of action on B cell lymphoma by chimeric anti-CD20 monoclonal antibody
    Oyama, T
    Kagami, Y
    Seto, M
    Morishima, Y
    LEUKEMIA, 2001, 15 (10) : 1667 - 1667
  • [24] Developing anti-CD19 antibody-based combinations in lymphoma
    Kuruvilla, John
    LANCET ONCOLOGY, 2020, 21 (07): : 870 - 872
  • [25] Laboratory and clinical studies of high anti-lymphoma potency with anti-CD20 veltuzumab and differentiation from rituximab
    Goldenberg, D. M.
    Chang, C.
    Rossi, E. A.
    Cardillo, T. M.
    Wegener, W. A.
    Teoh, N.
    Leonard, J. P.
    Fayad, L. E.
    Coiffier, B.
    Morschhauser, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [26] Anti-CD20 (rituximab) in follicular lymphoma
    McLaughlin, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S51 - S51
  • [27] Anti-lymphoma effects of mono/combination therapy with anti-CD20 and anti-HL-DR mabs in human lymphoma cell lines
    DeNardo, G
    Tobin, E
    Chan, K
    Bradt, B
    DeNardo, S
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (04) : 512 - 513
  • [28] Anti-CD20 antibody mediated apoptosis is dependent on caspase 3 activation.
    Mathas, S
    Bommert, K
    Dörken, B
    Mapara, MY
    BLOOD, 1998, 92 (10) : 405A - 405A
  • [29] IMPACT OF CRYOPRESERVATION ON BISPECIFIC ANTI-CD20/ANTI-CD19 CAR T-CELLS ENERGY METABOLISM AND ACTIVATION
    Poimenidou, M.
    McAllister, D.
    Nguyen, C. T.
    Johnson, B.
    Fenske, T.
    Hematti, P.
    Hamadani, M.
    Schenider, D.
    Kearl, T.
    Dwinell, M.
    Shah, N.
    CYTOTHERAPY, 2024, 26 (06) : S189 - S190
  • [30] Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo
    Zhiqiang Luo
    Jiaru Shi
    Qiyao Jiang
    Guohua Yu
    Xiaorui Li
    Zhuoying Yu
    Jianxun Wang
    Yuanyuan Shi
    Molecular Biomedicine, 4
12345